금융 뉴스 허브

Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?

Pharmaceutical stocks have been one of the best places to invest over the past year. Choosing between these two funds is really a question about how you want to own what comes next.

Sector rotation reveals new buying opportunities (even with the S&P 500 near record highs)

Art Hogan, chief market strategist at B. Riley Wealth, argues that a broad S&P 500 position can ride a changing market leadership cycle.

Which Global Real Estate ETF Is the Better Buy: State Street’s RWO or Xtrackers’ HAUZ?

One fund calls itself global but keeps over half its money in the U.S. The other goes fully international at a fifth of the cost.

Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH?

IBB has delivered stronger returns than IYH but with dramatically sharper swings in both directions. Here is how to decide which trade-off fits your portfolio.

Amazon in talks to acquire AI startup Decart for $7B: WSJ

Oil tops $105 as Houthi attacks on Saudi Arabia raise inflation fears

Is Media Scrutiny of FCFS’s Pawn and Lending Mix Altering The Investment Case For FirstCash Holdings (FCFS)?

In recent days, FirstCash Holdings has drawn heightened attention after Jim Cramer spotlighted its pawn-focused model and the risks tied to its American First Finance consumer lending arm, while analy ...

Which Healthcare ETF Is the Better Buy: Simplify’s Active PINK or VanEck’s Pharma-Focused PPH?

VanEck offers lower costs and higher dividends with a concentrated pharma focus, while Simplify provides broader healthcare exposure and donates profits to breast cancer research.

AI boom echoes 1997 Asian financial crisis: SocGen's Albert Edwards

Dow Jones Futures Rise As Trump Claims Russia-Ukraine 'Energy Ceasefire'; ASML, Nvidia Chipmaker Taiwan Semi Earnings Loom

Futures: Trump claimed Ukraine and Russia have agreed to an "energy ceasefire." Earnings for ASML and Nvidia chipmaker Taiwan Semi will be key for AI stocks.

Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?

One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility.

Stock Futures Edge Higher to Start Week Ahead of Bank Reports

All three major stock indexes ended last week higher as a relentless bull market driven by AI spending enters its fourth year.